openPR Logo
Press release

Autoimmune Disease Diagnostics Market 2019 Assessment by Treatment type, Diagnosis and Technology Involved by Thermo Fisher Scientific, bioMérieux SA, Beckman Coulter, Inc., Siemens Healthcare Pvt Ltd,Inova Diagnostics,etc

02-05-2019 01:22 PM CET | Health & Medicine

Press release from: Market Research Future

Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market: Information by Disease Type (Systemic Autoimmune Disease and Others), Localized Autoimmune Disease (Dot Blot, and Line Blot), End-User (Hospitals, Diagnostics Centers, and Others) - Global Forecast till 2023

Market Scenario

Autoimmune disease is a disorder where body’s own immune system starts attacking the healthy cells instead of foreign particles and disease-causing agents. The rising awareness about autoimmune disorders, technological advancement in the healthcare sector and rise in number of cases of autoimmune diseases are the factors driving the growth of the global autoimmune disease diagnostics market.

Avail Sample Research@ https://www.marketresearchfuture.com/sample_request/6715

Moreover, strategic collaborations and aggressive strategies by major players are also contributing to the growth of the market. For instance, in May 2018, Myriad Genetics, Inc. has acquired Counsyl, Inc. for USD 375 million, Counsyl is a global leader in genetic testing and personalized medicine segment.

Key Players

Some of the key players in the global autoimmune disease diagnostics market are Thermo Fisher Scientific, bioMérieux SA, Beckman Coulter, Inc., Siemens Healthcare Private Limited,Inova Diagnostics, Bio-rad Laboratories, AstraZeneca, EUROIMMUN AG, F. Hoffmann-la Roche, Inc.,Myriad Genetics, Inc., Hemagen Diagnostics, Inc., and Trinity Biotech Plc.

Segmentation

The global autoimmune disease diagnostics market has been segmented on the basis of disease type, test type, and end-user.

The market, by disease type, has been classified as systemic autoimmune disease, and localized autoimmune disease. The systemic autoimmune disease segment has been further classified into psoriasis, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus (SLE), and others. Localized autoimmune disease segment has been divided into inflammatory bowel disease, thyroid, type 1 diabetes, and others.

On the basis of test type, the market has been segregated into western blotting, enzyme-linked immunosorbent assay (ELISA), double immune diffusion, dot blot, counter immune-electrophoresis, line blot, immunofluorescence assays (IFA), multiplex immunoassay, agglutination, and others.

The end-user segment has been divided into, has been segmented into hospitals, diagnostics centers, research laboratories, and others

Regional Analysis

The Americas are likely to dominate the global autoimmune disease diagnostics market due to the well-established healthcare sector, adoption of advance technology, and rising prevalence of autoimmune disorders. The European market is expected to be the second-largest autoimmune disease diagnostics market. The growing healthcare industry, presence of major market players in the region, and increasing automation in laboratories are the factors responsible for growth of the autoimmune disease diagnostics market in the region. Asia-Pacific is anticipated to be the fastest-growing autoimmune disease diagnostics market during the forecast period owing to the increase in population, rising prevalence of autoimmune disorders, and initiatives by government and private organizations for development of healthcare sector. The market in the Middle East & Africa is likely to account for the smallest share of the global autoimmune disease diagnostics market.

Brows Complete Research Report@ https://www.marketresearchfuture.com/reports/autoimmune-disease-diagnostics-market-6715

Research Methodology

MRFR leverages its in-house expertise for drawing insightful conclusions into the market. Extensive primary and secondary research are undertaken which include SEC filings, interviews with stakeholders across the value chain, whitepaper references, etc. for backing the research findings. Top-down and bottom-up approaches employed validate the authenticity of the statistical observations available in the report. Furthermore, a multi-layer verification process is applied for eliminating deviations and discrepancies.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autoimmune Disease Diagnostics Market 2019 Assessment by Treatment type, Diagnosis and Technology Involved by Thermo Fisher Scientific, bioMérieux SA, Beckman Coulter, Inc., Siemens Healthcare Pvt Ltd,Inova Diagnostics,etc here

News-ID: 1561230 • Views:

More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035. Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035. Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CAGR
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034. Cheese packaging
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by

All 5 Releases


More Releases for Autoimmune

Autoimmune Polyglandular Syndrome Market analysis reveals CAGR of 6.20 percent t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoimmune Polyglandular Syndrome Type 1 Market - (By Diagnosis (Serum Autoimmune Screen, End-organ Function Tests, Blood Tests, Others), Age of Onset (Childhood, Adult, Adolescent), Treatment (Medication, Hormone Replacement Therapy, Others), Dosage Form (Tablet, Capsule, Others), Route of Administration (Oral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)),
Reshaping Autoimmune Therapy Landscape: Protheragen Announces Small Molecule Dru …
Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune diseases. New York, USA - Protheragen announced its comprehensive small molecule drug development services aimed at advancing innovative therapies for a range of autoimmune conditions. From target identification to preclinical studies, Protheragen leverages its expertise in small molecule drug design and development to offer tailored services that provide biotech and pharmaceutical companies
Autoimmune Disease Diagnosis Market - Strength in Knowledge, Defying Autoimmune …
Newark, New Castle, USA: The "Autoimmune Disease Diagnosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Autoimmune Disease Diagnosis Market: https://www.growthplusreports.com/report/autoimmune-disease-diagnosis-market/7616 This latest report researches the industry structure,
Autoimmune Drugs Market: Understanding How They Work and Their Importance in Tre …
Allied Market Research recently said Autoimmune diseases are a group of disorders in which the body's immune system attacks its own healthy tissues, mistaking them for foreign invaders. These diseases can affect any part of the body, including the joints, skin, and organs. They can be debilitating, chronic, and sometimes life-threatening. Autoimmune drugs are medications that help to suppress or modulate the immune system's response to prevent it from attacking
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html To reduce effects of such hindrances, the new entrants are
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include